Karachi, GlaxoSmithKline Pakistan Limited informed Pakistan Stock Exchange that Mr. Abdul Samad, Chief Financial Officer and Executive Director on the Board of the Company has resigned from the Board with effect from April 02, 2021. The Board of Directors have accepted the resignation of Mr. Samad and offered their gratitude for his contributions as CFO and Director.
GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).